Derisking Psychiatric Drug Development The NIMH's Fast Fail Program, A Novel Precompetitive Model

被引：17
|
作者：
Grabb, Margaret C. [1 ]
Cross, Alan J. [2 ]
Potter, William Z. [1 ]
McCracken, James T. [3 ]
机构：
[1] NIMH, NIH, 6001 Execut Blvd,Room 7203,MSC 9645, Rockville, MD 20852 USA
[2] AstraZeneca Neurosci Innovat Med Unit, Cambridge, MA USA
[3] UCLA Semel Inst Neurosci, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2016年 / 36卷 / 05期
关键词：
NERVOUS-SYSTEM; AUTISM; PHARMACOLOGY; DISORDERS;
D O I：
10.1097/JCP.0000000000000536
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：419 / 421
页数：3
相关论文
共 50 条
  • [21] Model Informed Drug Development: Novel Oncology Agents are Lost in Translation
    Mayawala, Kapil
    de Alwis, Dinesh P.
    Sachs, Jeffrey R.
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 6564 - 6566
  • [22] Development and characterization of a novel lipohydrogel nanocarrier: repaglinide as a lipophilic model drug
    Ebrahimi, Hossein Ali
    Javadzadeh, Yousef
    Hamidi, Mehrdad
    Jalali, Mohammad Barzegar
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2016, 68 (04) : 450 - 458
  • [23] Considerations for a business model for the effective integration of novel biomarkers into drug development
    Frueh, Feliz W.
    PERSONALIZED MEDICINE, 2008, 5 (06) : 641 - 649
  • [24] Industrial Perspective on the Benefits Realized from the FDA's Model-Informed Drug Development Paired Meeting Pilot Program
    Galluppi, Gerald R.
    Brar, Satjit
    Caro, Luzelena
    Chen, Yuan
    Frey, Nicolas
    Grimm, Hans Peter
    Rudd, Deanne Jackson
    Li, Chi-Chung
    Magee, Mindy
    Mukherjee, Arnab
    Nagao, Lee
    Purohit, Vivek S.
    Roy, Amit
    Salem, Ahmed Hamed
    Sinha, Vikram
    Suleiman, Ahmed A.
    Taskar, Kunal S.
    Upreti, Vijay V.
    Weber, Benjamin
    Cook, Jack
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 110 (05) : 1172 - 1175
  • [25] On the Discovery and Development of Pimavanserin: A Novel Drug Candidate for Parkinson’s Psychosis
    Uli Hacksell
    Ethan S. Burstein
    Krista McFarland
    Roger G. Mills
    Hilde Williams
    Neurochemical Research, 2014, 39 : 2008 - 2017
  • [26] On the Discovery and Development of Pimavanserin: A Novel Drug Candidate for Parkinson's Psychosis
    Hacksell, Uli
    Burstein, Ethan S.
    McFarland, Krista
    Mills, Roger G.
    Williams, Hilde
    NEUROCHEMICAL RESEARCH, 2014, 39 (10) : 2008 - 2017
  • [27] ISMILE - A NOVEL CIRCUIT SIMULATION PROGRAM WITH EMPHASIS ON NEW DEVICE MODEL DEVELOPMENT
    YANG, AT
    KANG, SM
    26TH ACM/IEEE DESIGN AUTOMATION CONFERENCE, 1989, : 630 - 633
  • [28] Development of a novel PGY2 pharmacogenomics and drug information residency in a personalized medicine program
    Obeng, Aniwaa Owusu
    Weitzel, Kristin
    Johnson, Julie
    PHARMACOTHERAPY, 2013, 33 (10): : E261 - E261
  • [29] The Effect on Drug Development of the National Cancer Institute's Cancer Therapy Evaluation Program
    Zwiebel, James
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (03) : 157 - 159
  • [30] Development of a novel human stratum corneum model, as a tool in the optimization of drug formulations
    Shakel, Zinaida
    Nunes, Claudia
    Costa Lima, Sofia A.
    Reis, Salette
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 569
12345